1 |
Magdalena B, Łukasz K, Agnieszka W, Kamila C, Katarzyna W, Rutkowska K, Barbara S, Rafał P. Broadening the phenotypic spectrum of the presumably epilepsy-related SV2A gene variants. Epilepsy Research 2023. [DOI: 10.1016/j.eplepsyres.2023.107101] [Reference Citation Analysis]
|
2 |
Perinelli MG, Riva A, Amadori E, Follo R, Striano P. Learnings in Developmental and Epileptic Encephalopathies: what do we know? Expert Rev Neurother 2023. [PMID: 36726225 DOI: 10.1080/14737175.2023.2176221] [Reference Citation Analysis]
|
3 |
Bishop KI, Isquith PK, Gioia GA, Knupp KG, Scheffer IE, Nabbout R, Specchio N, Sullivan J, Auvin S, Helen Cross J, Guerrini R, Farfel G, Galer BS, Gammaitoni AR. Fenfluramine treatment is associated with improvement in everyday executive function in preschool-aged children (<5 years) with Dravet syndrome: A critical period for early neurodevelopment. Epilepsy Behav 2023;138:108994. [PMID: 36463826 DOI: 10.1016/j.yebeh.2022.108994] [Reference Citation Analysis]
|
4 |
Mukhin KY, Pylaeva OA, Bobylova MY, Freydkova NV. Lamotrigine (Sazar) in the treatment of epilepsy: four years of experience in Svt. Luka's Association of Medical institutions for the Diagnosis, Treatment, and Rehabilitation of Nervous System Diseases and Epilepsy. Rus ž det nevrol 2022;17:8-36. [DOI: 10.17650/2073-8803-2022-17-3-8-36] [Reference Citation Analysis]
|
5 |
Adams J, Askham AV, Hess P, Huggett B. Spotted around the web: Autism services for Indigenous people; seizure meds; brain waves. Spectrum 2022. [DOI: 10.53053/fsvg9895] [Reference Citation Analysis]
|